FDA applicant

Asset Medikal

Istanbul, TR1 decision2025–20250 recalls

FDA records 1 decision for Asset Medikal (Istanbul, TR) in 2025: 1 510(k) clearance. All are in product code LHI (Set, I.V. Fluid Transfer). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general hospital panel, where it files most

How often FDA has decided Asset Medikal’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2025high 1 (2025)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2025.

FIG. 1 — Asset Medikal by year, 2025–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Asset Medikal’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Asset”

FDA records each applicant name separately; these may or may not be the same firm.

Asset Medikal Tasarim As. 4 Asset Medikal Tasarim San Tic As. 1 Asset Medikal Tasarim Sanayi VE Ticaret A.S. 1 Asset Scientific & Pharmaceutical, Inc. 1 Asset Ent., Sdn Bhd 1

Asset Medikal

Which product codes does it file in?

What has FDA decided for it lately?

Other applicant names beginning “Asset”